INTEGRATED BIOPHARMA INC Quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities in USD from Q3 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Summary
Integrated Biopharma Inc quarterly/annual Interest Paid, Excluding Capitalized Interest, Operating Activities history and growth rate from Q3 2016 to Q3 2024.
  • Integrated Biopharma Inc Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending September 30, 2024 was $12K, a 20% increase year-over-year.
  • Integrated Biopharma Inc annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2024 was $42K, a 2.44% increase from 2023.
  • Integrated Biopharma Inc annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2023 was $41K, a 63.7% decline from 2022.
  • Integrated Biopharma Inc annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $113K, a 43.8% decline from 2021.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $12K +$2K +20% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q3 2023 $10K -$1K -9.09% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q3 2022 $11K -$19K -63.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q3 2021 $30K -$27K -47.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q3 2020 $57K -$66K -53.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q3 2019 $123K -$78K -38.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q3 2018 $201K +$3K +1.52% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q3 2017 $198K +$3K +1.54% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q3 2016 $195K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.